41,381 Shares in Core Laboratories Inc. (NYSE:CLB) Purchased by Intech Investment Management LLC

Intech Investment Management LLC purchased a new stake in shares of Core Laboratories Inc. (NYSE:CLB) in the fourth quarter, according to the company in its most recent disclosure with the SEC. The institutional investor purchased 41,381 shares of the oil and gas company’s stock, valued at approximately $716,000. Intech Investment Management LLC owned about 0.09% of Core Laboratories at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of the business. Eagle Asset Management Inc. purchased a new stake in Core Laboratories in the third quarter worth $3,531,000. Fisher Asset Management LLC increased its position in shares of Core Laboratories by 19.5% during the third quarter. Fisher Asset Management LLC now owns 990,267 shares of the oil and gas company’s stock valued at $18,350,000 after buying an additional 161,278 shares during the period. The Manufacturers Life Insurance Company raised its stake in Core Laboratories by 19.1% in the third quarter. The Manufacturers Life Insurance Company now owns 21,511 shares of the oil and gas company’s stock worth $399,000 after buying an additional 3,457 shares in the last quarter. Quantbot Technologies LP purchased a new stake in Core Laboratories in the third quarter worth about $211,000. Finally, FMR LLC lifted its holdings in Core Laboratories by 182.9% in the third quarter. FMR LLC now owns 17,057 shares of the oil and gas company’s stock worth $316,000 after buying an additional 11,028 shares during the period. Hedge funds and other institutional investors own 97.81% of the company’s stock.

Analysts Set New Price Targets

Separately, Citigroup upgraded Core Laboratories from a “sell” rating to a “neutral” rating and upped their target price for the stock from $15.00 to $16.00 in a report on Wednesday, March 12th. One investment analyst has rated the stock with a sell rating and four have given a hold rating to the stock. According to MarketBeat.com, Core Laboratories has a consensus rating of “Hold” and an average price target of $17.50.

Core Laboratories Price Performance

Shares of CLB opened at $15.31 on Monday. The firm’s 50-day simple moving average is $16.79 and its two-hundred day simple moving average is $18.17. Core Laboratories Inc. has a fifty-two week low of $12.95 and a fifty-two week high of $25.13. The stock has a market cap of $716.69 million, a PE ratio of 23.19, a price-to-earnings-growth ratio of 0.99 and a beta of 2.38. The company has a debt-to-equity ratio of 0.49, a quick ratio of 1.71 and a current ratio of 2.32.

Core Laboratories (NYSE:CLB) last posted its quarterly earnings data on Wednesday, January 29th. The oil and gas company reported $0.23 earnings per share for the quarter, meeting analysts’ consensus estimates of $0.23. Core Laboratories had a return on equity of 16.24% and a net margin of 5.99%. Analysts anticipate that Core Laboratories Inc. will post 0.96 earnings per share for the current fiscal year.

Core Laboratories Dividend Announcement

The company also recently disclosed a quarterly dividend, which was paid on Monday, March 3rd. Shareholders of record on Monday, February 10th were paid a dividend of $0.01 per share. The ex-dividend date of this dividend was Monday, February 10th. This represents a $0.04 dividend on an annualized basis and a yield of 0.26%. Core Laboratories’s dividend payout ratio is currently 6.06%.

Core Laboratories Profile

Core Laboratories Inc provides reservoir description and production enhancement services and products to the oil and gas industry in the United States, and internationally. It operates through Reservoir Description and Production Enhancement segments. The Reservoir Description segment includes the characterization of petroleum reservoir rock and reservoir fluid samples to enhance production and improve recovery of crude oil and gas from its clients' reservoirs.